Bitget App
Aqlliroq savdo qiling
Kripto sotib olishBozorlarSavdoFyuchersEarnKvadratKo'proq

LABS stock price forecast

How will LABS stock perform in 2026 and 2030?

This page primarily displays the projected price range for LABS stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of LABS, the development trends of MediPharm Labs Corp., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for LABS. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines MediPharm Labs Corp.'s financial performance and industry trends to provide short-term price predictions for LABS stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year LABS stock price forecast

Price target:
0.15 CAD
+114.29%
Based on 1-year price forecasts from 32 analysts, the highest estimate is 0.21 CAD, while the lowest estimate is 0.07 CAD.

Analyst rating for LABS

Based on ratings from 24 analysts over the past three months, the overall consensus is Sell.

Strong buy
8
Buy
0
Hold
0
Sell
7
Strong sell
9

Tez-tez beriladigan savollar

How has LABS's EPS performed recently?

LABS's EPS is projected to reach 0.000 CAD next quarter. Explore more MediPharm Labs Corp. financial data and stay up to date on the company's latest developments on the LABS stock details page.

What is the revenue forecast for LABS next quarter?

MediPharm Labs Corp.'s revenue is projected to reach 11.82M CAD CAD in the next quarter. You can view MediPharm Labs Corp.'s revenue and earnings on the LABS stock details page.

What is the price target for LABS?

Based on analyst estimates, the most likely target price for LABS over the next 12 months is 0.15 CAD, with a projected high of 0.21 CAD and a projected low of 0.07 CAD. To track whether this target is reached within the next year, you can view the LABS stock price chart on the LABS stock details page to check the current LABS stock price, or follow the latest developments related to LABS on the LABS Stock News page.

What is the analyst rating for LABS?

We collected ratings from 24 analysts who have evaluated LABS stock over the past three months. Most analysts maintain a Sell outlook, and after aggregating all opinions, the overall consensus rating is Sell. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of LABS stock in 2030?

Based on price forecasts and analyses of MediPharm Labs Corp. from Wall Street analysts and major investment banks, LABS is projected to trade between 0.14 CAD and 0.70 CAD in 2030.

LABS stock chart

LABS stock details

LABS aksiya narxining o'zgarishi

Oxirgi savdo kunida, LABS aksiya 0.07 CAD narxda yopildi, kun uchun narx o'zgarishi 7.69%.

Aksiya fyucherslari savdosi

Bitget haqida

Dunyodagi birinchi universal birja (UEX) bo'lib, u foydalanuvchilarga nafaqat kriptovalyutalar, balki aksiyalar, ETF, valyutalar, oltin va real aktivlar (RWA) bilan ham savdo qilish imkonini beradi.
Batafsil
TSX/
LABS stock price forecast